Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02763319
Title A Trial to Evaluate the Efficacy and Safety of MOR208 With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (B-MIND)
Acronym B-MIND
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors MorphoSys AG
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | ROU | POL | NZL | ITA | ISR | HUN | HRV | GBR | FRA | FIN | ESP | DEU | CZE | CAN | AUT | AUS


No variant requirements are available.